A detailed history of Nomura Asset Management CO LTD transactions in Pfizer Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 1,649,613 shares of PFE stock, worth $46.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,649,613
Previous 1,814,592 9.09%
Holding current value
$46.2 Million
Previous $52.2 Million 12.38%
% of portfolio
0.17%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $4.27 Million - $4.9 Million
-164,979 Reduced 9.09%
1,649,613 $45.8 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $757,848 - $984,361
29,003 Added 1.62%
1,814,592 $52.2 Million
Q3 2023

Nov 03, 2023

SELL
$32.09 - $37.51 $1.93 Million - $2.25 Million
-60,112 Reduced 3.26%
1,785,589 $59.2 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $5.96 Million - $6.9 Million
165,088 Added 9.82%
1,845,701 $67.7 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $3.87 Million - $5.03 Million
98,153 Added 6.2%
1,680,613 $68.6 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1.06 Million - $1.39 Million
-25,419 Reduced 1.58%
1,582,460 $81.1 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $5.8 Million - $7.08 Million
-132,599 Reduced 7.62%
1,607,879 $70.4 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $13.2 Million - $15.7 Million
284,075 Added 19.51%
1,740,478 $91.3 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $3.08 Million - $3.82 Million
-67,394 Reduced 4.42%
1,456,403 $75.4 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $11.6 Million - $17.2 Million
281,323 Added 22.64%
1,523,797 $90 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $2.26 Million - $2.9 Million
57,609 Added 4.86%
1,242,474 $53.4 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $2.84 Million - $3.22 Million
79,124 Added 7.16%
1,184,865 $46.4 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $292,903 - $330,336
8,746 Added 0.8%
1,105,741 $40.1 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $1.61 Million - $2.05 Million
48,226 Added 4.6%
1,096,995 $40.4 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $1.61 Million - $1.89 Million
-50,748 Reduced 4.62%
1,048,769 $38.5 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $1.62 Million - $1.96 Million
-53,645 Reduced 4.65%
1,099,517 $36 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $802,412 - $1.15 Million
29,686 Added 2.64%
1,153,162 $37.6 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $3.67 Million - $4.16 Million
-111,434 Reduced 9.02%
1,123,476 $44 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $1.71 Million - $2.22 Million
-52,685 Reduced 4.09%
1,234,910 $44.4 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $1.62 Million - $1.82 Million
43,921 Added 3.53%
1,287,595 $55.8 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $5.42 Million - $5.96 Million
-144,562 Reduced 10.41%
1,243,674 $52.8 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $3.09 Million - $3.52 Million
80,291 Added 6.14%
1,388,236 $60.6 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $1.5 Million - $1.82 Million
-43,555 Reduced 3.22%
1,307,945 $57.6 Million
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $757,253 - $807,308
-22,961 Reduced 1.67%
1,351,500 $49 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $3.03 Million - $3.51 Million
94,888 Added 7.42%
1,374,461 $48.8 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $1.4 Million - $1.48 Million
41,997 Added 3.39%
1,279,573 $46.3 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $5.44 Million - $5.99 Million
175,429 Added 16.52%
1,237,576 $44.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,062,147
1,062,147 $35.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.